Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy
Authors
Keywords
-
Journal
PLoS One
Volume 11, Issue 1, Pages e0146697
Publisher
Public Library of Science (PLoS)
Online
2016-01-20
DOI
10.1371/journal.pone.0146697
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac Tissue Engineering
- (2014) Marc N. Hirt et al. CIRCULATION RESEARCH
- Hypertrophic Cardiomyopathy
- (2014) Barry J. Maron et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
- (2014) Gang Wang et al. NATURE MEDICINE
- Up-Regulation of hERG K+ Channels by B-RAF
- (2014) Tatsiana Pakladok et al. PLoS One
- THY-1 Receptor Expression Differentiates Cardiosphere-Derived Cells with Divergent Cardiogenic Differentiation Potential
- (2014) Nuria Gago-Lopez et al. Stem Cell Reports
- The RASopathies
- (2013) Katherine A. Rauen Annual Review of Genomics and Human Genetics
- Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias
- (2013) Jiaxian Wang et al. BIOMATERIALS
- Three-dimensional filamentous human diseased cardiac tissue model
- (2013) Zhen Ma et al. BIOMATERIALS
- Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium
- (2013) Irene C. Turnbull et al. FASEB JOURNAL
- Biowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
- (2013) Sara S Nunes et al. NATURE METHODS
- Design and formulation of functional pluripotent stem cell-derived cardiac microtissues
- (2013) N. Thavandiran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased afterload induces pathological cardiac hypertrophy: a new in vitro model
- (2012) Marc N. Hirt et al. BASIC RESEARCH IN CARDIOLOGY
- Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes
- (2012) Christine L. Mummery et al. CIRCULATION RESEARCH
- Genetic engineering of somatic cells to study and improve cardiac function
- (2012) R. D. Kirkton et al. EUROPACE
- Unknown
- (2012) Valentina Sala et al. MOLECULAR MEDICINE
- Myocyte-Depleted Engineered Cardiac Tissues Support Therapeutic Potential of Mesenchymal Stem Cells
- (2012) Gregory W. Serrao et al. TISSUE ENGINEERING PART A
- Cardio-facio-cutaneous syndrome: Does genotype predict phenotype?
- (2011) Judith E. Allanson et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Neonatal Mouse–Derived Engineered Cardiac Tissue
- (2011) W.J. de Lange et al. CIRCULATION RESEARCH
- Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture
- (2011) Nathaniel L. Tulloch et al. CIRCULATION RESEARCH
- SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells
- (2011) Nicole C Dubois et al. NATURE BIOTECHNOLOGY
- Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology
- (2011) Sebastian Schaaf et al. PLoS One
- Genetics of hypertrophic cardiomyopathy
- (2010) Tetsuo Konno et al. CURRENT OPINION IN CARDIOLOGY
- Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
- (2010) Xonia Carvajal-Vergara et al. NATURE
- GermlineBRAFmutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum
- (2009) Anna Sarkozy et al. HUMAN MUTATION
- Role of Animal Models in HCM Research
- (2009) Rhian Shephard et al. Journal of Cardiovascular Translational Research
- MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
- (2008) Anthony J. Muslin CLINICAL SCIENCE
- What is principal component analysis?
- (2008) Markus Ringnér NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now